Volume 87, Issue 5 pp. 993-995
Valvular and Structural Heart Diseases

Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve

Jochen Wöhrle MD

Corresponding Author

Jochen Wöhrle MD

Department of Internal Medicine II, University of Ulm, Ulm, Germany

Correspondence to: Jochen Wöhrle, Department of Internal Medicine II, University of Ulm, Ulm, Germany. E-mail [email protected]Search for more papers by this author
Christoph Rodewald MD

Christoph Rodewald MD

Department of Internal Medicine II, University of Ulm, Ulm, Germany

Search for more papers by this author
Wolfgang Rottbauer MD

Wolfgang Rottbauer MD

Department of Internal Medicine II, University of Ulm, Ulm, Germany

Search for more papers by this author
First published: 23 June 2015
Citations: 22

Conflict of interest: Nothing to report.

Abstract

Transfemoral aortic valve implantation (TAVI) for the treatment of pure native aortic insufficiency is not routine clinical practice. Absent cusp calcification, missing landmarks in combination with no perfect valve control during release with first-generation TAVI devices resulted in a high rate for need of a second valve or relevant residual aortic insufficiency. We report the first case with a native pure aortic valve insufficiency at high surgical risk successfully treated by implantation of the repositionable and completely retrievable Lotus valve, resulting in a well-controlled and safe procedure with no residual aortic insufficiency. © 2015 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.